vete is a young scientist who faces the challenges of being a woman in science on a daily basis. Her story is not only shaped by laboratories and academia, but also by the influences and inspirations that have guided her journey.

CISM has been strengthening regional scientific cooperation to monitor parasite resistance to antimalarial drugs, a phenomenon of concern to public health experts due to its spread and the rapid pace at which it has been advancing in different parts of the world.

A study recently published in the scientific journal BMC Pregnancy and Childbirth, under the PRECISE project (PREgnancy Care Integrating translational Science, Everywhere), reinforces the need to include pregnant women in the continuous surveillance of disease impacts during public health emergencies, such as the COVID-19 pandemic.

The warning comes from a recent scientific review that brings together evidence on the diagnosis, treatment, and clinical management of neonatal malaria and malaria in young infants. The study is particularly relevant for Mozambique, where malaria remains one of the leading causes of illness and child mortality, especially affecting children under five years of age and pregnant women.

he multicenter clinical trial SII-qHPV/MC-03, which evaluates the CERVAVAC vaccine (marketed by Serum Institute of India Pvt. Ltd.), is being conducted in South Africa, Kenya, and Mozambique. In Mozambique, the study is being implemented by the Centro de Investigação em Saúde de Manhiça (CISM), under the leadership of Principal Investigator Tacilta Nhampossa.

Num contexto em que os níveis de poluição atmosférica continuam a preocupar investigadores e profissionais de saúde, o projecto procura gerar evidências científicas sobre a qualidade do ar em zonas urbanas e rurais, contribuindo para a consciencialização pública e para o desenvolvimento de políticas ambientais mais eficazes.

The district of Mopeia, in Zambézia province, will host in the coming months the implementation of an innovative project led by the Manhiça Health Research Centre (CISM), which aims to evaluate the diagnostic performance of tongue swab testing for the detection of Tuberculosis (TB) among contacts of bacteriologically confirmed pulmonary TB patients.

The AFRICAI-RI project, the Pan-African Research Infrastructure for Collaborative Biomedical Imaging and Artificial Intelligence in Respiratory Care, was designed to significantly contribute to improving healthcare in Sub-Saharan Africa through the establishment of the region's first interconnected and multi-institutional medical imaging research infrastructure.

On 28 April, Francisco Manyanga Secondary School hosted the 2nd Edition of the Malaria Conference & Fair (MCF), an event that brought together students, researchers, health professionals, policy makers and cooperation partners, with the aim of strengthening awareness, promoting the sharing of scientific evidence, and mobilising society in the fight against malaria.

Dr Tuelo Mogashoa, from the Botswana Harvard AIDS Institute Partnership (BHP), recently completed her PhD, becoming the first fellow of the TAGENDi programme (TESA Addressing Regional Gaps in Gender and Diversity in Clinical Research Capacity) under the TESA (Trial of Excellence in Southern Africa) consortium, which is coordinated by the Manhiça Health Research Centre.